CTMC A joint venture between Resilience MD Anderson Cancer Center

Cell Therapy Manufacturing Center (CTMC) is a joint venture based in Houston, Texas, specializing in cell therapy manufacturing. The company employs 62 people and generates $50 million in annual revenue. CTMC focuses on providing state-of-the-art manufacturing solutions for complex biologics, particularly in the field of cell therapy. Their services are designed to support academic institutions and biotechnology companies seeking to advance cancer treatment through innovative cell therapies. CTMC distinguishes itself through its unique partnership between Resilience, a leading technology organization in complex biologics manufacturing, and MD Anderson Cancer Center, the nation's top-ranked cancer center. This collaboration combines expertise in both research and manufacturing, accelerating the translation of cutting-edge cell therapy research into effective treatments for patients. For more information about CTMC's services and capabilities, visit their website at ctmc.com.